Filtered By:
Source: UCLA Newsroom: Health Sciences
Condition: Epilepsy
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 12 results found since Jan 2013.
Quick magnesium treatment fails to improve stroke outcomes, but study has silver lining
In the first study of its kind, a consortium led by UCLA physicians found that giving stroke patients intravenous magnesium within an hour of the onset of symptoms does not improve stroke outcomes.
However, the 8-year trial did find that with the help of paramedics in the field, intravenous medications can frequently be administered to stroke victims within that so-called "golden hour," during which they have the best chance to survive and avoid debilitating, long-term neurological damage.
The latter finding is a "game-changer," said Dr. Jeffrey Saver, director of the UCLA Stroke Center and a professor of ...
Source: UCLA Newsroom: Health Sciences - February 13, 2014 Category: Universities & Medical Training Source Type: news
UCLA study shows promise, offers hope for brain hemorrhage patients
A new endoscopic surgical procedure has been shown to be safer and to result in better outcomes than the current standard medical treatment for patients who suffer strokes as a result of brain hemorrhages, UCLA neurosurgeons have announced.
The findings from their potentially groundbreaking, randomized, controlled phase 2 clinical trial, which was conducted at multiple medical centers, were presented last week at the International Stroke Conference in Honolulu.
"These exciting results offer a glimmer of hope for a condition that most doctors have traditionally considered hopeless," said principal investigator...
Source: UCLA Newsroom: Health Sciences - February 11, 2013 Category: Universities & Medical Training Source Type: news
UCLA researchers provide first evidence of how obstructive sleep apnea damages the brain
Courtesy of Rajesh Kumar
Brains with obstructive sleep apnea (left) and without
UCLA researchers have reported the first evidence that obstructive sleep apnea contributes to a breakdown of the blood–brain barrier, which plays an important role in protecting brain tissue.
The discovery, reported in the Sept. 1 issue of the Journal of Neuroimaging, could lead to new approaches for treating obstructive sleep apnea, which affects an estimated 22 million American adults. The disorder causes frequent interruptions in breathing during sleep because the airways narrow or become blocked.
The blood–brain barrier limits harmful...
Source: UCLA Newsroom: Health Sciences - September 1, 2015 Category: Universities & Medical Training Source Type: news
Spacing out after staying up late? Here ’s why
Ever sleep poorly and then walk out of the house without your keys? Or space out while driving to work and nearly hit a stalled car?A new study led by UCLA ’sDr. Itzhak Fried is the first to reveal how sleep deprivation disrupts brain cells ’ ability to communicate with each other. Fried and his colleagues believe that disruption leads to temporary mental lapses that affect memory and visual perception. Their findings are published online today by Nature Medicine.“We discovered that starving the body of sleep also robs neurons of the ability to function properly,” said Fried, the study’s senior author, a profess...
Source: UCLA Newsroom: Health Sciences - November 6, 2017 Category: Universities & Medical Training Source Type: news
Pesticides and Parkinson's: UCLA researchers uncover further proof of a link
For several years, neurologists at UCLA have been building a case that a link exists between pesticides and Parkinson's disease. To date, paraquat, maneb and ziram — common chemicals sprayed in California's Central Valley and elsewhere — have been tied to increases in the disease, not only among farmworkers but in individuals who simply lived or worked near fields and likely inhaled drifting particles.
Now, UCLA researchers have discovered a link between Parkinson's and another pesticide, benomyl, whose toxicological effects still linger some 10 years after the chemical was banned by the U.S. Environment...
Source: UCLA Newsroom: Health Sciences - January 3, 2013 Category: Universities & Medical Training Source Type: news
WALL-E, meet EVA: 'Robo-doc' navigates on its own, frees doctors to focus on the critically ill
Ronald Reagan UCLA Medical Center, the world's first hospital to introduce a remote-presence robot into its neurological intensive-care unit in 2005, now welcomes the RP-VITA, the first robot able to navigate the hospital on its own.
UCLA staff affectionately dubbed the 5'5", 176-pound robot "EVA," for executive virtual attending physician. Unlike earlier models that physicians steered via a computer-linked joystick, this version drives on auto-pilot, freeing doctors to devote more time to patient care.
"During a stroke, the loss of a few minutes can mean the difference between preserving or losing brain func...
Source: UCLA Newsroom: Health Sciences - May 6, 2013 Category: Universities & Medical Training Source Type: news
Researchers ID more pesticides linked to Parkinson's, gene that increases risk
This report provides evidence for the relevance of ALDH inhibition in Parkinson's disease pathogenesis, identifies pesticides that should be avoided to reduce the risk of developing Parkinson's disease and suggests that therapies modulating ALDH enzyme activity or otherwise eliminating toxic aldehydes should be developed and tested to potentially reduce Parkinson's disease occurrence or slow its progression, particularly for patients exposed to pesticides," the study states.
The study was funded in part by the National Institute of Environmental Health Sciences (P01ES016732, R01ES010544, 5R21ES16446-2 and U54ES0120...
Source: UCLA Newsroom: Health Sciences - February 3, 2014 Category: Universities & Medical Training Source Type: news
Brain’s reaction to virtual reality should prompt further study, suggests new research by UCLA neuroscientists
UCLA neurophysicists have found that space-mapping neurons in the brain react differently to virtual reality than they do to real-world environments. Their findings could be significant for people who use virtual reality for gaming, military, commercial, scientific or other purposes.
“The pattern of activity in a brain region involved in spatial learning in the virtual world is completely different than when it processes activity in the real world,” said Mayank Mehta, a UCLA professor of physics, neurology and neurobiology in the UCLA College and the study’s senior author. “Since so many people are using virtual r...
Source: UCLA Newsroom: Health Sciences - November 25, 2014 Category: Universities & Medical Training Source Type: news
Oxytocin shows promise for improving social skills in autistic mice
UCLA
Dr. Daniel Geschwind
People with autism spectrum disorders have difficulty with social behavior and communication, which can make it challenging to form friendships, engage in routine conversations or pick up on the social cues that are second nature to most people. Similarly, mice with symptoms of autism show little interest in interacting or socializing with other mice.
A drug called risperidone has been shown to treat some symptoms of autism — including repetitive behaviors — in both humans and mice, but so far no medication has been found to help improve the ability to socialize.
In a study published online b...
Source: UCLA Newsroom: Health Sciences - January 27, 2015 Category: Universities & Medical Training Source Type: news
UCLA–Tel Aviv study suggests REM sleep helps the brain capture snapshots of dream images
When we sleep, we experience our most vivid dreams and vigorous brain activity during the rapid eye movement, or REM phase. Although scientists have long suspected that our eyes flicker in response to what our unconscious mind sees in our dreams, no one has been able to prove it.
Now, an international team of researchers led by UCLA’s Dr. Itzhak Fried is the first to demonstrate that during dreams, our eyes and brains respond similarly to how they react to images when we’re awake. Published in the Aug. 11 online edition of Nature Communications, the findings offer a rare glimpse into the working of individual brain...
Source: UCLA Newsroom: Health Sciences - August 12, 2015 Category: Universities & Medical Training Source Type: news
UCLA will lead $21 million, grant-funded study of epilepsy after traumatic brain injuries
A UCLA-led international consortium of academic research institutions has been awarded a $21 million grant from the National Institutes of Health to develop better ways to prevent epilepsy following traumatic brain injuries.Seven principal investigators will lead the grant at five institutions: the David Geffen School of Medicine at UCLA, Albert Einstein College of Medicine, University of Southern California, University of Melbourne and University of Eastern Finland. The investigators will collaborate in the fields of bioinformatics, molecular biology, cellular pathology, therapy discovery and the health sciences.UCLA, w...
Source: UCLA Newsroom: Health Sciences - January 30, 2017 Category: Universities & Medical Training Source Type: news
UCLA neuroscientists use weak electrical signal to stimulate human brain and improve memory
FINDINGSNeuroscientists at the David Geffen School of Medicine at UCLA have discovered precisely where and how to electrically stimulate the human brain to enhance people’s recollection of distinct memories. People with epilepsy who received low-current electrical pulses showed a significant improvement in their ability to recognize specific faces and ignore simila r ones.Eight of nine patients ’ ability to recognize the faces of specific people improved after receiving electrical pulses to the right side of the brain’s entorhinal area, which is critical to learning and memory. However, electrical stimulation deli...
Source: UCLA Newsroom: Health Sciences - October 24, 2017 Category: Universities & Medical Training Source Type: news
